Christianson Mark's Form 4 filing
Neuroone Medical Technologies Corp (NMTC) · filed Dec 26, 2023
- Accession no.
- 0001709738-23-000015
- Filed
- Dec 26, 2023
- Trade date
- Dec 21-22, 2023
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market sales total $16.4K. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Christianson MarkCIK 0001709738 | Officer (Business Development Director) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 21, 2023 | Common Stock | SSaleDisposed | −9,907 | $1.40 | −$13,869.8 | 340,687 | Direct | |
| Dec 22, 2023 | Common Stock | SSaleDisposed | −1,800 | $1.40 | −$2,520 | 338,887 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.